Nav: Home

Faster, less expensive test proven more effective in detecting bladder cancer

February 15, 2005

HOUSTON - Physicians now have a more dependable, less expensive tool to help detect bladder cancer earlier.

Researchers at The University of Texas M. D. Anderson Cancer Center found that a simple test that can be administered and read in the doctor's office was three times more effective than a conventional laboratory test for detecting bladder cancer.

In a study published in the February 16 issue of the Journal of the American Medical Association, researchers tested the NMP22 tumor marker assay in 1,331 patients at high risk for bladder cancer. Researchers determined through cystoscopy that 79 of the 1,331 patients examined had bladder cancer. The NMP22 assay was positive in 55 percent of the cases (44 out of 79 cases) while the conventional cytology test detected about 16 percent of malignancies (12 out of 76 cases).

This demonstrated that the NMP22 test was significantly more sensitive than cytology, or the conventional laboratory test, says H. Barton Grossman, M.D., professor in M. D. Anderson's Department of Urology and the study's lead author.

"Our challenge is to improve the detection of bladder cancer," says Grossman. "This test is easy and may save lives."

He cautions, however, that NMP22 should not be used alone to detect bladder cancer, but should be combined with bladder examination (cystoscopy) to provide an accurate diagnosis.

"No single procedure is 100 percent sensitive, so a combination of procedures is recommended," Grossman says.

The findings are seen as an advance in screening for bladder cancer, Grossman says, which is the fifth most common cancer in the United States. Five-year survival is 95 percent for cancer caught early, but it is much lower for the 25 percent of bladder tumors that are advanced when first diagnosed. It is estimated that more than 60,000 people living in the U.S. will be diagnosed with bladder cancer this year; 13,000 are predicted to die of the disease.

Grossman led a team of researchers at M. D. Anderson and 23 academic, private practice, and veterans' facilities in 10 states who enrolled patients into the clinical trial that examined the effectiveness of these different diagnostic tests.

Patients enrolled in the trial were suspected of having bladder cancer because they had evidence of blood in their urine and met some of the risk factors associated with the disease, which include a history of smoking, exposure to certain chemicals, being over age 40 and painful and frequent urination. Tobacco use is the most common risk factor, accounting for about 50 percent of bladder cancer, Grossman says.

To conduct the study, a sample of urine collected from the patients was divided in half, and one part was used for the NMP22 test. The rest was used for a cytology test, which is the screening method physicians traditionally use. The cytology test looks for abnormal cells in the urine and must be sent to outside laboratories for evaluation. Patients may wait as long as a week to receive these results, according to Grossman, while the results of the NMP22 test can be read within 30 to 50 minutes in the doctor's office.

The patients also received a cystoscopy, which uses a flexible endoscope to examine the bladder. This low-risk procedure can be performed under local anesthesia in a doctor's office and is considered the "gold standard" of diagnostic tests, but can fail to detect some bladder cancers, says Grossman.

In this study, the researchers looked at the sensitivity as well as the specificity of cytology versus the NMP22 test. Sensitivity refers to how frequently the test picked up the existence of cancer; specificity refers to whether the test detected cancer that truly existed, and not false positives.

Although NMP22 was more sensitive in this study, cytology was more specific (99 percent versus 86 percent), meaning that the number of false positives was higher for the NMP22 test. Still, the authors say "the high specificity of cytology is offset by low sensitivity, ambiguous test results, expense, and time lag to obtain reports."
-end-
Co-authors of the study include, M. D. Anderson's Yu Shen, Ph.D.; Edward Messing, M.D., at the University of Rochester Medical Center; Mark Soloway, M.D., at the University of Miami School of Medicine; Kevin Tomera, M.D., at the Alaska Clinical Research Center; Giora Katz, M.D., at the Lake City Veterans Administration Hospital in Wisconsin; and Yitzhak Berger, M.D., with Associates in Urology in New Jersey.

Matritech, the Massachusetts company that produces the NMP22 test, sponsored the study. The test received FDA approval in 2004.

University of Texas M. D. Anderson Cancer Center

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

The Truth about Cancer: What You Need to Know about Cancer's History, Treatment, and Prevention
by Ty M Bollinger (Author)

Cancer touches more lives than you may think. According to the World Health Organization, one out of three women alive today, and one out of two men, will face a cancer diagnosis in their lifetime.

To Ty Bollinger, this isn’t just a statistic. It’s personal. After losing seven members of his family to cancer over the course of a decade, Ty set out on a global quest to learn as much as he possibly could about cancer treatments and the medical industry that surrounds the disease. He has written this book to share what he’s uncovered—some of which may shock you—and to give you... View Details


Radical Remission: Surviving Cancer Against All Odds
by Kelly A., PhD Turner (Author)

In her New York Times bestseller, Radical Remission: Surviving Cancer Against All Odds, Dr. Kelly A. Turner, founder of the Radical Remission Project, uncovers nine factors that can lead to a spontaneous remission from cancer—even after conventional medicine has failed.

While getting her Ph.D. at the University of California, Berkley, Dr. Turner, a researcher, lecturer, and counselor in integrative oncology, was shocked to discover that no one was studying episodes of radical (or unexpected) remission—when people recover against all odds without the help of... View Details


The Cancer-Fighting Kitchen, Second Edition: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
by Rebecca Katz (Author), Mat Edelson (Author)

This new and revised edition of the IACP award-winning cookbook brings the healing power of delicious, nutritious foods to those whose hearts and bodies crave a revitalizing meal, through 150 new and updated recipes.

Featuring science-based, nutrient-rich recipes that are easy to prepare and designed to give patients a much-needed boost by stimulating appetite and addressing treatment side effects including fatigue, nausea, dehydration, mouth and throat soreness, tastebud changes, and weight loss. A step-by-step guide helps patients nutritionally prepare for all phases of... View Details


Anticancer: A New Way of Life
by David Servan-Schreiber (Author)

Anticancer has been a bestselling phenomenon since Viking first published it in fall 2008. Now, a new edition addresses current developments in cancer research and offers more tips on how people living with cancer can fight it and how healthy people can prevent it. The new edition of Anticancer includes:

• The latest research on anticancer foods, including new alternatives to sugar and cautions about some that are now on the market
• New information about how vitamin D strengthens the immune system
• Warnings about common... View Details


The Emperor of All Maladies: A Biography of Cancer
by Siddhartha Mukherjee (Author)

Winner of the Pulitzer Prize, and now a documentary from Ken Burns on PBS, The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence.

Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly... View Details


The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies
by Dr. Nasha Winters ND FABNO L.Ac Dipl.OM (Author), Jess Higgins Kelley MNT (Author), Kelly Turner (Foreword)

The Optimal Terrain Ten Protocol to Reboot Cellular Health

Since the beginning of the twentieth century, cancer rates have increased exponentially―now affecting almost 50 percent of the American population. Conventional treatment continues to rely on chemotherapy, surgery, and radiation to attack cancer cells. Yet research has repeatedly shown that 95 percent of cancer cases are directly linked to diet and lifestyle. The Metabolic Approach to Cancer is the book we have been waiting for―it offers an innovative, metabolic-focused nutrition protocol that... View Details


The Cancer Revolution: A Groundbreaking Program to Reverse and Prevent Cancer
by Leigh Erin Connealy (Author)

When it comes to cancer, conventional doctors are trained to treat their patients exclusively with surgery, radiation, and chemotherapy. These methods are grueling on the whole body - and they don't treat beyond the tumor or the cancer itself. The focus is on the disease, not the whole person - and because of this, the outcomes in conventional medicine can be bleak.

But it doesn't have to be this way. Dr. Leigh Erin Connealy has developed a whole-person approach to treating cancer - and these treatments have helped thousands of patients through her Cancer Center for Healing. In... View Details


Outsmart Your Cancer: Alternative Non-Toxic Treatments That Work (Second Edition) With CD
by Tanya Harter Pierce (Author)

This easy-to-read alternative treatment guide could save your life. Outsmart Your Cancer explodes the myths about alternative cancer treatments and explains why non-toxic methods are more effective than conventional ones. This second edition of Outsmart Your Cancer includes new chapters, an audio CD with inspiring recovery testimonials from cancer survivors, and an incredible amount of valuable information. Twenty-one different alternative methods are discussed along with real-life stories of people who completely recovered from a variety of advanced or late-stage cancers using alternative... View Details


Cancer: 50 Essential Things to Do: 2013 Edition
by Greg Anderson (Author)

The ground-breaking classic guide to surviving cancer?now completely updated!

Revised and updated for the first time since 1999, this invaluable guide to cancer recovery offers an easily accessible plan for patients and family members. Written by a cancer survivor, the book is an inspiring, action-oriented roadmap for those who choose to adopt a stance of hope and take charge of their diagnosis.

With penetrating insights that bring together more than two decades of scientifically supported research and experience, Anderson reveals a step-by-step holistic action plan... View Details


Anti-Cancer Smoothies: Healing With Superfoods: 35 Delicious Smoothie Recipes to Fight Cancer, Live Healthy and Boost Your Energy
by Linda H. Harris (Author)

Anti-Cancer Diet, Cancer Fighting Foods, and Cancer Nutrition

Whether you have cancer or you're at risk of cancer because of your family history - the way you eat can have a major impact on your health and your ability to fight or manage your disease. Cancer is notorious for sapping the strength and nutrition out of a person's body. You'll need to replace a lot of the vitamins, nutrients and minerals that certain drugs and treatments deplete.

The Anti-Cancer Smoothies in this book are made of healthy and tasty vegetables, fruits, spices and herbs that are known to fight cancer.... View Details

Best Science Podcasts 2017

We have hand picked the best science podcasts for 2017. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Manipulation
We think we're the ones who control what we see, read, think and remember. But is that true? Who decides? And who should decide? This hour, TED speakers reveal just how easily we can be manipulated. Guests include design ethicist Tristan Harris, MSNBC host Ali Velshi, psychologist Elizabeth Loftus, and neuroscientist Steve Ramirez.
Now Playing: Science for the People

#444 The V-Word (Rebroadcast)
This week, we're looking at the social and biological science of female sex organs. We'll talk to Dr. Anthony Atala, director of the Wake Forest Baptist Medical Center Institute for Regenerative Medicine, about the creation and use of lab-grown vaginas. Biology professor Marie Herberstein exposes the bias against female genitalia in scientific studies. And science writer Emily Anthes tells us about the history and promising future of female condoms.